Ambient ID has unveiled its LabTrack business information management system for diagnostic laboratories and hospitals.
The diagnostic sample-tracking and management system uses radio-frequency identification technology and comprehensive data-gathering methods to identify, track, and trace specimens as they move through the laboratory testing supply chain.
LabTrack is available as a closed-loop standalone system or as an add-on module that can be fully integrated with an institution’s information technology systems. Pricing is based on specimen volume.
NetLims has received FDA market approval for its AutoFusion blood bank management system.
“The FDA market approval of AutoFusion allows NetLims to provide a complete and integrative solution to hospitals in the U.S. as well as an excellent standalone solution for blood banks,” says Gonen Ziv, chief operating officer for NetLims. The product is designed to meet the needs of blood banks, transfusion services, and donor centers.
Data Innovations has purchased David G. Rhoads Associates, a developer of quality assurance, statistical analysis, and laboratory management software for clinical labs.
Data Innovations will integrate Rhoads’ EP Evaluator laboratory statistics software with its Instrument Manager and Laboratory Production Manager middleware systems. “We strive to offer our customers the most comprehensive solutions to increase efficiency and improve workflow, and the addition of EP Evaluator to our portfolio shows that commitment,” says Hunter Bagwell, sales and marketing manager for Data Innovations.
Rhoads will continue to operate as David G. Rhoads Associates and will be based in Data Innovations’ office in South Burlington, Vt.
Sunquest Information Systems has enhanced its laboratory and point-of-care solution suite with new modules for molecular testing and expanded functionality for its applications geared toward general laboratory, microbiology, blood bank and transfusion management, and point-of-care phlebotomy.
New capabilities for molecular testing include set alerts that automatically notify staff about significant shifts in patient disease status or when patient values exceed a specific threshold; integrated reporting with standard epidemiology information; functionality to compare molecular test results against results generated by traditional microbiology testing; and the ability to report a wide range of results for infectious disease testing and monitoring.
Among Sunquest’s other new offerings are expanded capabilities for automating blood bank processing procedures; the ability to scan manually reported results from reference laboratories; and functionality for improving nonlaboratory workflow in point-of-care specimen collection.
Novovision has added a dedicated flow cytometry module to its NovoPath anatomic pathology lab workflow management, specimen tracking, and reporting platform.
The new module saves up to 30 minutes over the typical manual reporting process and interfaces with numerous flow cytometry instruments. It presents flow cytometry data as part of a comprehensive Novo-Path patient report and writes the data to the standard NovoPath electronic patient file.
Antek HealthWare has launched an HL7 reconciler module for its LabDaq laboratory information system.
The module, designed for any laboratory with a reference lab interface, helps lab professionals match reflexed reference lab results with the correct patient. It can also assist with modified profile identification numbers received from the reference lab.
“Too often, laboratory efficiencies are interrupted by changes in the reference lab test compendium which have not been communicated or shared with the POL,” says Paul Taylor, vice president of sales and marketing for Antek. “The addition of an HL7 reconciler alleviates this problem and increases patient safety.”
BioImagene, a provider of digital pathology products, has introduced Companion Algorithms.
The specialized algorithms, which are intended for use with the company’s Virtuoso suite of Web-based software, help pathologists quantitatively assess specific diagnostic tests used to determine appropriate cancer treatment options for patients.
Companion Algorithms can help pathologists interpret digitized images of such diagnostic cancer tests as immunohistochemistry and fluorescence in situ hybridization. The digitized images can be generated using any of BioImagene’s iScan slide-scanning systems, including Coreo, Concerto, or Solo.
BioImagene received FDA clearance in February for use of one of its Companion Algorithms in the company’s Pathiam IVD imaging software for HER2/neu immunohisto-chemistry tests. The iScan Coreo and associated software are used to detect and provide a quantitative measurement of HER2/neu to determine breast cancer patients’ candidacy for treatment with Genentech’s Herceptin (trastuzumab) breast cancer drug.
“The Herceptest, the first FDA-approved companion diagnostic, is used to identify the subset of breast cancer patients who overexpress the HER2/neu protein and will, therefore, have a high probability of responding to Herceptin,” says Robert Monroe, MD, PhD, chief medical officer for BioImagene. “BioImagene’s FDA-cleared HER2/neu Companion algorithm improves the accuracy and reproducibility of Herceptest interpretation.”
BioImagene offers other Companion Algorithms for breast cancer and plans to develop algorithms for diagnostic tests for such cancers as prostate, colon, and lung.
Mercy Medical Center, Sioux City, Iowa, has gone live with the laboratory results functionality of Brunston Integrated Systems’ Brio2000 Link laboratory-provider links software. Mercy, which is owned by Novi, Mich.-based Trinity Health System, implemented the order-entry functionality of the Brio2000 Link in 2007.
Dr. Aller is director of automated disease surveillance and team lead for disaster preparedness Focus B, Los Angeles County Department of Public Health. He can be reached at firstname.lastname@example.org. Hal Weiner is president of Weiner Consulting Services, LLC, Florence, Ore. He can be reached at email@example.com.